Navigation Links
Gloucester Pharmaceuticals Receives Fast Track Designation for,Romidepsin in Peripheral T-Cell Lymphoma

tatus for CTCL and PTCL has also been designated by the FDA. Romidepsin is in clinical trials for a variety of other hematological malignancies and solid tumors, including hormone refractory prostate cancer, pancreatic cancer and multiple myeloma. These trials and others are being conducted by the Company or the National Cancer Institute (NCI) under a Cooperative Research and Development Agreement (CRADA) with the Company.

About Gloucester Pharmaceuticals, Inc.

Gloucester Pharmaceuticals, Inc. is a privately-held, venture-backed company that develops and commercializes innovative products for the treatment of cancer patients. Gloucester is headquartered in Cambridge, MA. For more information on Gloucester and our clinical development program visit our website at www.gloucesterpharma.com or call 888-474-2825.

Contact

Media:
KMorrisPR
Kathryn Morris, 845-635-9828
kathryn@kmorrispr.com
or
Gloucester Pharmaceuticals
Beverly Holley, 617-583-1362
beverly.holley@gloucesterpharma.com


'"/>




Page: 1 2 3

Related medicine technology :

1. Gloucester Pharmaceuticals Reports Positive Interim Phase II Data on Romidepsin for T-Cell Lymphomas at the 2007 American Society of Clinical Oncology Annual Meeting
2. Gloucester Pharmaceuticals Reports on Romidepsin and Erlotinib Combination in Non-Small Cell Lung Cancer Presented at American Association of Cancer Research Annual Meeting
3. Gloucester Pharmaceuticals Announces Multiple Presentations of Preclinical Romidepsin Data at American Association of Cancer Research Annual Meeting
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
11. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea

Post Your Comments:
(Date:12/2/2009)..., TAMPA, Fla., Dec. 2 Laser Spin...ve spinal surgery, is pleased to announce a partn...r an extensive six-month negotiation and clinical ...st healthcare provider of minimally invasive spina... Effective immediately, patients with United Healt...
(Date:12/2/2009)... , LAKE FOREST, Ill., Dec. 2 /PRNewswire-Firs...provider of clinical information and medication de...cquired Salt Lake City-based TheraDoc, a clinical ...lance systems. TheraDoc,s two leading products, In...tant(TM), join Hospira,s expanding portfolio of me...
(Date:12/2/2009)..., WALTHAM, Mass. and NEW YORK, Dec. 2 /PRNewswi...Amex: ILI ) and NYU Langone Medical Center announ...on with Duke University on the genetics of osteoar...ne First" version of the Annals of Rheumatic Disea...pidpdf/ard.2009.113043v1.pdf . Results from th...
Breaking Medicine Technology:Laser Spine Institute Partners with United Healthcare 2Laser Spine Institute Partners with United Healthcare 3Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings 2Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings 3Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings 4Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings 5Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 2Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 3Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 4Young Ballerinas May Face Heart Bone Risks 47452 1Isis Highlights New Clinical Data on Anti Cancer Antisense Drugs Featured at ASCO 47448 1Isis Highlights New Clinical Data on Anti Cancer Antisense Drugs Featured at ASCO 47448 2Isis Highlights New Clinical Data on Anti Cancer Antisense Drugs Featured at ASCO 47448 3Isis Highlights New Clinical Data on Anti Cancer Antisense Drugs Featured at ASCO 47448 4Millennium Research Groups New Perception Pulse Product Offers Clients an Innovative New Customer Behavior and Loyalty Tracking Tool 47444 1Millennium Research Groups New Perception Pulse Product Offers Clients an Innovative New Customer Behavior and Loyalty Tracking Tool 47444 2Millennium Research Groups New Perception Pulse Product Offers Clients an Innovative New Customer Behavior and Loyalty Tracking Tool 47444 3
...nual Meeting of the American Society of,Clinical O...SciClone Pharmaceuticals,Inc. (Nasdaq:SCLN) and S...d product candidate thymalfasin (ZADAXIN(r), thymo...ase 2 clinical trial,treating patients diagnosed w... form of skin cancer. Results showed that thymalfa...
...4, 2007 /PRNewswire-FirstCall/ -- Kosan,Bioscience...hase 2,monotherapy trial showing that tanespimycin...in patients with metastatic melanoma,including on...led,prior chemotherapy (within 6 weeks of initiati...sion-free survival for more than,six months and 20...
Other Medicine Technology:Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity,of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO 2Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity,of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO 3Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity,of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO 4
(Date:12/2/2009)...California Institute of Technology (Caltech) have ...e, the previously mysterious process by which long... enzymes called ubiquitin ligases to proteins that...et proteins for destruction by protein-degrading c... ligases build ubiquitin chains very rapidly by tr...
(Date:12/2/2009)...state-specific antigen (PSA) value of less than or...iation therapy (EBRT) are less likely to have a ca...g to a study in the December 1 issue of the Intern...ics, the official journal of the American Society ... prostate cancer patient are monitored after a pat...
(Date:12/2/2009)...ment therapy (CIMT) is a potentially effective for...ebral palsy, but more research is needed, accordin...mber issue of Physical Therapy (PTJ), the scient...ciation (APTA). The review, which analyzed 21 inte...ed that further research should focus on the frequ...
(Date:12/2/2009)...s been a top name in the medical supply industry s..., professional staff, and a keen understanding of ...established itself as a provider of ground ambulan... supplies distributor. The distinguished history o...next phase with the redesign and launch of its web...
(Date:12/2/2009)...eries to increase awareness of prostate cancer and...of early detection , Denv...ilies, friends and neighbors – at all fitnes... Rudolph Ramble 5K. The Rudolph Ramble 5K is a pa...aunched by the Prostate Conditions Education Coun...
Breaking Medicine News(10 mins):Health News:Caltech scientists show how ubiquitin chains are added to cell-cycle proteins 2Health News:Caltech scientists show how ubiquitin chains are added to cell-cycle proteins 3Health News:Caltech scientists show how ubiquitin chains are added to cell-cycle proteins 4Health News:PSA value at 2 years post-treatment can predict long-term survival in prostate cancer patients 2Health News:Report shows CIMT may improve arm use in children with hemiplegic cerebral palsy 2Health News:From A to B and Everything In-between; AB First Aid Launch New Web Storefront 2Health News:From A to B and Everything In-between; AB First Aid Launch New Web Storefront 3Health News:PACE Race Returns with Denver's Rudolph Ramble 2Health News:PACE Race Returns with Denver's Rudolph Ramble 3Health News:PACE Race Returns with Denver's Rudolph Ramble 4
...y,announced today that it has begun enrollment for... locally recurrent or metastatic breast,cancer. Th... Nexavar(R),(sorafenib) tablets in combination wit...uticals and Onyx Pharmaceuticals,is currently appr...
...Nurse Education at Mercer, ATLANTA, Nov. 12 Pied... and Mercer University President William,D. Underw...ont Healthcare,Chair in Nursing that will benefit ...hip of Piedmont Healthcare and,Mercer University, ...
...searchers add , MONDAY, Nov. 12 (HealthDay News) -...rs late in youngsters with attention deficit hyper...in a normal pattern, concludes a study by research...n regions at the front of the brain,s outer mantle...
... stroke, study says , , MONDAY, Nov. 12 (H...arettes a day have a 21 percent greater risk of de...k for heart disease, a new study found. , Women wh...tension, the study said. , The findings are publis...
...ranholm, Attorney General Mike Cox and Michigan Ch...ed off the 4th Annual "Support MI Troops",fundrais...es funds to,support Michigan soldiers, sailors, an... order to raise funds for,soldiers who are sufferi...
... Premieres November 18 at 9 AM...Nearly every society on earth is,affected by diabe...ng,humanity today. Currently, more than 246 millio...cluding new,medications, monitoring devices and me...
Other Medicine News:Health News:Northwestern University and ACORN Commence National Enrollment for Metastatic Breast Cancer Study 2Health News:Northwestern University and ACORN Commence National Enrollment for Metastatic Breast Cancer Study 3Health News:Piedmont Healthcare Funds Nursing Chair at Mercer University 2Health News:Piedmont Healthcare Funds Nursing Chair at Mercer University 3Health News:ADHD Delays Growth of Certain Brain Areas 2Health News:Smoking Boosts Blood Pressure in Women 2Health News:Governor Granholm, Attorney General Cox, & Michigan Chamber Kick Off 4th Annual 'Support MI Troops' Fundraising Drive Proceeds to Benefit the Bob Woodruff Family Fund 2Health News:Discovery Health Travels the World to Present the Groundbreaking Documentary - Diabetes: A Global Epidemic 2Health News:Discovery Health Travels the World to Present the Groundbreaking Documentary - Diabetes: A Global Epidemic 3Health News:Discovery Health Travels the World to Present the Groundbreaking Documentary - Diabetes: A Global Epidemic 4
...00 is a powerful PTFE membrane vacuum pump designe...s Ideally suited for use with up to two rotary e...nts including vacuum ovens, concentrators, gel dry...s PEEK head resistant to chemicals and heat load ...
...vant offers several different two-stage, oil-seale...for standard freeze drying applications. Each pump...rn Kit) and and Oil Mist Filter (EMF-10). The GBOR...p the oil clean without losing oil. The EMF10 filt...
...ted Gel Pump™ is a quiet, compact, efficient...ng applications. The oil-free design and TEFLON&re...maximum reliability and reduced maintenance. Uniqu...pre-trap for pump protection, and a 1-liter post-p...
...vant offers several different two-stage, oil-seale...for standard freeze drying applications. Each pump...rn Kit) and and Oil Mist Filter (EMF-10). The GBOR...p the oil clean without losing oil. The EMF10 filt...
Medicine Products: